Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial,Blood

当前位置： X-MOL 学术 › Blood › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
Blood ( IF 21.0 ) Pub Date : 2017-09-21 , DOI: 10.1182/blood-2017-04-775841
Isabelle Krämer ₁ , Stephan Stilgenbauer ₂ , Sascha Dietrich ₁ , Sebastian Böttcher _{3,

4} , Matthias Zeis ₅ , Michael Stadler ₆ , Jörg Bittenbring ₇ , Lutz Uharek ₈ , Christof Scheid ₉ , Ute Hegenbart ₁ , Anthony Ho ₁ , Michael Hallek ₉ , Michael Kneba ₃ , Norbert Schmitz ₅ , Hartmut Döhner ₂ , Peter Dreger ₁

Affiliation

1 Department of Medicine V, University of Heidelberg 2 Department of Medicine III, University of Ulm 3 Department of Medicine II, University of Schleswig-Holstein 4 Department of Medicine III, University Medical Center Rostock 5 Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Hospital St. Georg 6 Department of Hematology Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School 7 Department of Internal Medicine I, Saarland University Medical School 8 Division of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin 9 Department of Medicine I, University of Cologne

中文翻译：

高危 CLL 的异基因造血细胞移植：GCLLSG CLL3X 试验的 10 年随访

1 海德堡大学医学 V 系 2 乌尔姆大学医学 III 系 3 石勒苏益格-荷尔斯泰因大学医学 II 系 4 罗斯托克大学医学中心医学 III 系 5 血液学、肿瘤学和干细胞移植系， Asklepios 医院 St. Georg 6 血液学系汉诺威医学院止血、肿瘤学和干细胞移植 7 内科 I，萨尔大学医学院 8 血液学、肿瘤学和肿瘤免疫学系，查理特大学医学院 9 医学 I 系, 科隆大学

更新日期：2017-09-21

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11